Last edition
News about Industrial talks
Angelini Pharma, Quiver Bioscience Ink USD 120 Million Pact to Develop Genetic Epilepsy Therapies
Angelini Pharma and Quiver Bioscience have signed a multi-year collaboration to develop novel therapies for genetic epilepsies, combining AI-driven discovery tools with epilepsy expertise in a deal worth up to USD 120 million.
Industrial talks | 25/02/2026 | By News Bureau | 157
Boehringer Ingelheim India and NIPER Raebareli Sign MoU to Boost Pharma Education and Research
The MoU between NIPER Raebareli and Boehringer Ingelheim establishes a framework to strengthen academic and research collaboration in areas such as pharmaceutical technologies, novel drug delivery systems, joint research initiatives, academic exchange and capability-building programmes.
Industrial talks | 23/02/2026 | By News Bureau
TuHURA Biosciences Files IND for TBS-2025 in Relapsed/Refractory mutNPM1 AML
TuHURA Biosciences has filed an IND with the FDA to evaluate its VISTA-targeting antibody TBS-2025 in combination with a menin inhibitor for relapsed/refractory mutNPM1 AML.
Industrial talks | 20/02/2026 | By News Bureau | 211
BioNTech files patent lawsuit against Moderna over COVID-19 vaccine technology
German biotechnology firm BioNTech has filed a patent infringement lawsuit against U.S.-based vaccine maker Moderna in a federal court in Delaware. The case centers on Moderna’s updated COVID-19 vaccine, mNEXSPIKE, which BioNTech claims uses technology protected under its patents.
Industrial talks | 20/02/2026 | By Darshana | 164
India Ratings and Research (Ind-Ra) has retained a neutral outlook on India’s pharmaceutical sector for FY27, projecting revenue growth of around 10 percent year on year. The growth is expected to be driven by sustained domestic demand and rising momentum in the contract development and manufacturing organisation segment.
Industrial talks | 19/02/2026 | By Darshana | 156
Daiichi Sankyo Submits sNDA in Japan for Datroway in First-Line Metastatic TNBC
Daiichi Sankyo files supplemental application in Japan for Datroway as a first-line treatment for metastatic triple negative breast cancer based on phase III trial data.
Industrial talks | 13/02/2026 | By News Bureau | 173
Sanofi Removes CEO Paul Hudson Amid Stalled Turnaround
Sanofi has removed chief executive officer Paul Hudson following a stalled turnaround effort and growing pressure around the performance of its vaccine business, marking a significant leadership shift at the French pharmaceutical major.
Industrial talks | 12/02/2026 | By Darshana | 183
Ribo and Madrigal Enter Global Licensing Deal for siRNA Programmes Targeting MASH
Suzhou Ribo Life Science and Madrigal Pharmaceuticals have signed a worldwide licensing agreement covering six pre-clinical siRNA programmes for metabolic dysfunction-associated steatohepatitis, with potential milestone payments of up to USD 4.4 billion.
Industrial talks | 12/02/2026 | By News Bureau | 221
Genesys Spine Reports Positive Multicentre Study Results for SIros SI Joint Fusion System
Prospective multicentre data show significant pain reduction, improved function and strong fusion outcomes with the SIros Lateral Sacroiliac Joint Fusion System.
Industrial talks | 09/02/2026 | By News Bureau | 106
UK MHRA Updates Safety Information on Semaglutide Over Rare NAION Vision Risk
UK MHRA flags a very rare risk of NAION linked to semaglutide, urging patients to seek immediate medical attention for sudden changes in vision.
Industrial talks | 07/02/2026 | By News Bureau | 564
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy